COVID-19: Drug Targets and Potential TreatmentsCarmen Gil, Ana Martı́nez, Tiziana Ginex et al.|Journal of Medicinal Chemistry|2020Cited by 469
Identification of Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical PropertiesDongwei Kang, Xinyong Liu, Erik De Clercq et al.|Journal of Medicinal Chemistry|2019Cited by 87
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety ProfilesBoshi Huang, Xinyong Liu, Wen‐Ming Chen et al.|Journal of Medicinal Chemistry|2019Cited by 77
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIsDongwei Kang, Xinyong Liu, Da Feng et al.|Acta Pharmaceutica Sinica B|2019Cited by 51
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening MethodsTiziana Ginex, Carmen Gil, Victoria Castro et al.|Pharmaceuticals|2021Cited by 42